FDA Approves First mRNA Influenza Vaccine
The U.S. Food and Drug Administration has approved mFLUSIVA (mRNA-1010), a new vaccine against seasonal influenza, for use in all adults 50 years and older.
Nasal DNA Vaccine Protects Against Tuberculosis
Researchers have developed an experimental therapeutic nasal DNA vaccine for tuberculosis.
New HIV Vaccine Could Protect Against Development of HIV Infection and AIDS
Scientists have developed a new HIV vaccine that has the potential to protect humans from developing HIV infection and AIDS.
BCG Vaccine Linked to Changes in Brain Immunity and Alzheimer’s Biomarkers
The Bacillus Calmette-Guérin accine may alter immune activity around the brain and change levels of a protein closely associated with Alzheimer’s disease in older adults without evidence of the condition.
High-Dose Flu Vaccine Significantly Lowers Risk of Developing Alzheimer’s (2026)
A UTHealth study found adults 65 and older had a lower risk of developing Alzheimer’s disease after receiving a high-dose flu vaccine.
Opioid Overdose: Are Vaccines the Answer?
Opioid overdose vaccines in development could save lives.
Advancements in Cancer Vaccines
Cancer vaccines are proving to be a pillar of personalized treatment.
Early Vaccine Development: The Challenging Case of the West Nile Virus
While there are many vaccines, not every promising vaccine has progressed to market, such as the vaccine for West Nile virus.
Flu Vaccine, Even with Infection, Reduces Risk of Heart Attack and Stroke
The Statens Serum Institut in Copenhagen found that flu vaccines may protect against heart attack and stroke, even if the flu is still developed after vaccination.
Responding to the Opioid Crisis
Opioid vaccines are being developed to save lives.